Key Considerations For Launching Pharmaceutical Products In Emerging Markets
In light of growing revenue opportunities from emerging markets, we highlight tactics and successful examples for companies to leverage in overcoming challenges of low disease awareness and changing practice patterns.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
Leading industry experts have spoken to In Vivo about how investment, a change in mindset and a fresh approach to policy may allow Italy to kick-start its biotech ecosystem.
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.